Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

MarketScan data (2011–2022) identified 11,311 treated patients; 51.8% were high thromboembolic risk, and HCT control frequently exceeded the 45% guideline threshold despite ongoing therapy. Phlebotomy ...

Please provide your email address to receive an email when new articles are posted on . Aaron T. Gerds, MD, MS, spoke with Healio about the REVEAL study, results of which were presented at this year’s ...

Metairie clinic outlines why hematocrit, CBC testing, blood pressure and individualized follow-up matter during ...

Rusfertide effectively maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 weeks. Patients switching from placebo to rusfertide achieved rapid and ...

Neonatal polycythemia is a condition in which a newborn has an unusually high concentration of red blood cells. In this guide ...